Oncology / Radiation Therapy - Related Articles

The articles below have been published in peer-reviewed journals. To read about our Oncology patients or watch videos about our Oncology patients, please visit www.vetcancerspecialists.com.

Flow Cytometric Characterization and Clinical Outcome of CD4+ T-Cell Lymphoma in Dogs- 67 Cases

Avery PR, Burton J, Bromberek JL, Seelig DM, Elmslie R, et al. et al. J Vet Intern Med, 2014 Mar-Apr; 28 (2): 538-46

Liposomal clodronate treatment for tumour macrophage depletion in dogs with soft-tissue sarcoma

Guth AM, Hafeman SD, Elmslie RE, et al. Vet Comp Oncol. 2013 Dec; 11 (4): 296-305

Evaluation of a B-cell leukemia-lymphoma 2-specific radiolabeled peptide nucleic acid-peptide conjugate for scintigraphic detection of neoplastic lymphocytes in dogs with B-cell lymphoma

Kimberly A. Statham-Ringen, DVM, et al. AJVR, Vol 73, No 5, May 2012

A Randomized Trial Investigating the Efficacy and Safety of Water Soluble Micellar Paclitaxel (Paccal Vet) for Treatment of Nonresectable Grade 2 or 3 Mast Cell Tumors in Dogs

DM Vail, H von Euler, AW Rusk, L Barber, C Clifford, R Elmslie, et al. J Vet Intern Med, 2012 March: 1-10

Non-Thermal Irreversible Electroporation (N-TIRE) and Adjuvant Fractionated Radiotherapeutic Multimodal Therapy for Intracranial Malignant Glioma in a Canine Patient

Garcia PA, Pancotto T, Rossmeisl JH Jr, Henao-Guerrero N, Gustafson NR, et al. Technol Cancer Res Treat. 2011 Feb; 10 (1): 73-83

Molecular Imaging of Canine B-cell Lymphoma Using an Anti-bcl-2 Peptide Nucleic Acid-Peptide Conjugate

Ringen KS, Selting KA, Lattimer J, Bryan JN, Henry CJ, Green J, Jia F, Lewis MR. American Journal of Veterinary Research, (In press) 2011.

Canine Lingual Lymphoma: A Retrospective Review of 8 Cases (2000-2010)

BM Twigg, CJ Henry, TA Rocha, R Elmslie, et al. Veterinary Cancer Society Proceedings Nov. 2010, San Diego, pp:67.

Evaluation of liposomal clodronate for treatment of malignant histiocytosis in dogs

S Hafeman, C London, R Elmslie et al. Cancer Immunology, Immunotherapy March 2010, 59(3): 441-452.

Comparison of Somatostatin Analogues and Conventional Imaging Modalities for Staging of Canine B-Cell Lymphoma

Ringen KS, Selting KA, Lattimer J, Bryan JN, Villamil JA, Henry CJ, Lewis MR. Proceedings of the 29th Veterinary Cancer Society Annual Conference, Austin, TX, October 16-19 2009, 13.

Metronomic Therapy with Cyclophosphamide and Piroxicam Effectively Delays Tumor Recurrence in Dogs with Incompletely Resected Soft Tissue Sarcomas

R Elmslie, et al. J Vet Intern Med 2008; 22:1373–1379.

Changes in Regulatory T Cells in Dogs with Cancer and Associations with Tumor Type

O’Neill K, Guth A, Biller B, Elmslie R, et al. JVIM 2009 Jul-Aug; 23 (4): 875-81

Clinical Assessment of the Petscreen Proteomic Identification Profile for Canine Lymphoma

Villamil JA, Slater K, Statham (Ringen) K, Tyler J, Ratcliffe L, Shahid M, Mobasheri A, Henry CJ. Proceedings of the 28th Veterinary Cancer Society Annual Conference, Seattle, WA, October 18-21 2008, 11.

Molecular Imaging of the bcl-2 Oncogene in Canine B-Cell Lymphoma

Statham (Ringen) K, Green JA, Selting KA, Lattimer J, Bryan JN, Villamil JA, Henry CJ, Lewis MR. Proceedings of the 28th Veterinary Cancer Society Annual Conference, Seattle, WA, October 18-21 2008, 28.

Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma

D Kamstock, R Elmslie, et al., Cancer Immunol Immumother. 2007 Aug; 56 (8):1299-1309.

Continuous Low-Dose Oral Chemotherapy for Adjuvant Therapy of Splenic Hemangiosarcoma in Dogs

S Lana, L U’Ren, S Plaza, R Elmslie, et al. Journal of Veterinary Internal Medicine July 2007, 21(4) :764–769

Doxorubicin and BAY 12–9566 for the Treatment of Osteosarcoma in Dogs: A Randomized, Double-Blind, Placebo-Controlled Study

Antony S. Moore, William S. Dernell GK Ogilvie, O Kristal, R Elmslie, et al. Journal of Veterinary Internal Medicine. July 2007, 21(4): 783–790.

Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer

B.J. Biller, R Elmslie, et al. Veterinary Immunology and Immunopathol. 2007 Mar 15;116(1-2):69–78.

Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma

LW U’Ren, BJ Biller, R Elmslie, et al. JVIM 2007 Jan-Feb; 21(1): 113–120

Liposome–DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma

D Kamstock, A Guth, R Elmslie, et al. Cancer Gene Therapy (2006) 13, 306–317.

Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases

Steven Dow, R Elmslie, et al. HUMAN GENE THERAPY August 2005, 16:1-10.

Radiation Therapy for the Treatment of Urethral Sarcoma in a Cria

Gustafson NR, et al. JVIM 2005 Mar-Apr; 19 (2): 271-4

A preliminary assessment of whole-body radiotherapy interposed within a chemotherapy protocol for canine lymphoma

Gustafson NR, et al. Vet Comp Oncol. 2004 Sep;2(3):125-31

A Phase I Study Using Direct Combination DNA Injections for the Immunotherapy of Metastatic Melanoma

Walsh F, Gonzalez R, Dow S, Elmslie R, et al. Hum Gen Ther. 2000 Jun 10; 11 (9): 1355-68

Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases.

SW Dow, R Elmslie, LG Fradkin, et al. Gene Therapy. December 1999, 10(18): 2961-2972.

In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma.

SW Dow, R Elmslie, AP Willson, et al. J Clin Invest. June 1, 1998, 101(11): 2406-2414.

Radiotherapy with and without chemotherapy for localized lymphoma in 10 cats

R Elmslie, et al. Veterinary Radiology November 1991, 32(6 ):277–280.

Interleukins: biological properties and therapeutic potential

R Elmslie, et al. Journal of Veterinary Internal Medicine September 1991, 5(5):283–293.

Click Here For Emergency Care Referring Veterinarians Click Here